Effect observation of recombinant human endostatin combined with cisplatin on treatment of lung cancer complicated with malignant pleural effusion and malignant pericardial effusion

JIANG Lianping; TAN Yue; CHENG Shaohua; LI Anqi; WU Haixia

doi:10.7619/jcmp.201503005

JIANG Lianping, TAN Yue, CHENG Shaohua, LI Anqi, WU Haixia. Effect observation of recombinant human endostatin combined with cisplatin on treatment of lung cancer complicated with malignant pleural effusion and malignant pericardial effusion[J]. Journal of Clinical Medicine in Practice, 2015, (3): 20-22. DOI: 10.7619/jcmp.201503005

Citation:

JIANG Lianping, TAN Yue, CHENG Shaohua, LI Anqi, WU Haixia. Effect observation of recombinant human endostatin combined with cisplatin on treatment of lung cancer complicated with malignant pleural effusion and malignant pericardial effusion[J]. Journal of Clinical Medicine in Practice, 2015, (3): 20-22. DOI: 10.7619/jcmp.201503005

Citation:

JIANG Lianping, TAN Yue, CHENG Shaohua, LI Anqi, WU Haixia. Effect observation of recombinant human endostatin combined with cisplatin on treatment of lung cancer complicated with malignant pleural effusion and malignant pericardial effusion[J]. Journal of Clinical Medicine in Practice, 2015, (3): 20-22. DOI: 10.7619/jcmp.201503005

Effect observation of recombinant human endostatin combined with cisplatin on treatment of lung cancer complicated with malignant pleural effusion and malignant pericardial effusion

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Effect observation of recombinant human endostatin combined with cisplatin on treatment of lung cancer complicated with malignant pleural effusion and malignant pericardial effusion

Catalog

Export File

Citation

Format

Content